Obesity

Obesity Pharmaceuticals Patient Care Clinical Trials Market Competition Medications Public Health Drug Development Diabetes Weight Management

8 ARTICLES

12h ago

Study Finds Weight Loss Drugs Cut Alcohol Consumption by 68% in Obese Patients

Research from Dublin highlights the potential of GLP-1 receptor agonists to reduce alcohol cravings, though larger trials are needed to confirm findings.

Stories older than 24h

25 ARTICLES

last wk.

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

4 ARTICLES

2w ago

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

4 ARTICLES

2w ago

Allurion Technologies Stock Surges Following New Obesity Treatment Study Announcement

9 ARTICLES

3mo ago

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Particle.news

Obesity

Study Finds Weight Loss Drugs Cut Alcohol Consumption by 68% in Obese Patients

WHO to Endorse GLP-1 Weight-Loss Drugs, Calls for Global Access

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs

Poll Shows Americans Divided Over Weight-Loss Drugs for Obesity Treatment

Hims & Hers Debuts Super Bowl Ad Advocating for Affordable Weight-Loss Drugs

Allurion Technologies Stock Surges Following New Obesity Treatment Study Announcement

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Never miss stories about

Obesity